Leukemia Stem Cells in Hematologic Malignancies

Herausgegeben:Zhang, Haojian; Li, Shaoguang

• Gebundenes Buch

Produktbeschreibung

This book introduces readers to the biology of leukemia stem cells (LSCs) and emphasizes the necessity and importance of targeting LSCs in the treatment of hematopoietic malignancies. It addresses the role of leukemia stem cells in different leukemia diseases and molecular signatures, as well as the metabolic and epigenetic regulation of leukemia stem cell function. With regard to solid tumors, a significant number of blood cancers are believed to be derived from leukemia stem cells (LSCs), which are responsible for disease progression, relapse and drug resistance. Consequently, new therapeutic strategies need to be developed by focusing on the complete eradication of LSCs. Given its scope, the book offers a valuable asset for graduate students and scientists in the fields of cell biology and cancer research etc.

Produktdetails

• Advances in Experimental Medicine and Biology 1143
• Verlag: Springer / Springer Nature Singapore / Springer, Berlin
• Artikelnr. des Verlages: 978-981-13-7341-1
• 1st ed. 2019
• Seitenzahl: 240
• Erscheinungstermin: 5. August 2019
• Englisch
• Abmessung: 241mm x 160mm x 19mm
• Gewicht: 519g
• ISBN-13: 9789811373411
• ISBN-10: 9811373418
• Artikelnr.: 55284151

Autorenporträt

Dr. Haojian Zhang Dr. Shaoguang Li

Inhaltsangabe

Role of leukemia stem cells in pathogenesis of hematologic malignancies.- Leukemia stem cells in chronic myeloid leukemia.- Leukmeia stem cells in MLL-rearranged acute myeloid leukemia.- Interaction between leukmeia stem cells and bone marrow environment.- Molecular signatures of leukemia stem cells.- Metabolic regulation of leukemia stem cell function.- Epigenetic regulation of leukmeia stem cell function.- DNA instability and leukemia stem cell function.- Tumor suppressor genes in leukemia stem cells.- Targeting leukemia stem cells.- Leukemia stem cells and drug resistance.- Hypoxia and leukemia.